264 related articles for article (PubMed ID: 24842180)
1. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
[TBL] [Abstract][Full Text] [Related]
2. Perturbing NR2B-PSD-95 interaction relieves neuropathic pain by inactivating CaMKII-CREB signaling.
Xu F; Zhao X; Liu L; Song J; Zhu Y; Chu S; Shao X; Li X; Ma Z; Gu X
Neuroreport; 2017 Sep; 28(13):856-863. PubMed ID: 28746067
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal injection of selected peptide Myr-RC-13 attenuates bone cancer pain by inhibiting KIF17 and NR2B expression.
Ni K; Zhou Y; Sun YE; Liu Y; Gu XP; Ma ZL
Pharmacol Biochem Behav; 2014 Jul; 122():228-33. PubMed ID: 24726705
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
[TBL] [Abstract][Full Text] [Related]
5. The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.
Gu X; Zhang J; Ma Z; Wang J; Zhou X; Jin Y; Xia X; Gao Q; Mei F
Eur J Pain; 2010 May; 14(5):496-502. PubMed ID: 19815434
[TBL] [Abstract][Full Text] [Related]
6. CREB-regulated transcription coactivator 1 enhances CREB-dependent gene expression in spinal cord to maintain the bone cancer pain in mice.
Liang Y; Liu Y; Hou B; Zhang W; Liu M; Sun YE; Ma Z; Gu X
Mol Pain; 2016; 12():. PubMed ID: 27060162
[TBL] [Abstract][Full Text] [Related]
7. The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice.
Liu Y; Liang Y; Hou B; Liu M; Yang X; Liu C; Zhang J; Zhang W; Ma Z; Gu X
Pharmacol Biochem Behav; 2014 Sep; 124():19-26. PubMed ID: 24836181
[TBL] [Abstract][Full Text] [Related]
8. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCĪ³ signaling pathway.
Huang YN; Tsai RY; Lin SL; Chien CC; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2012 Apr; 229(2):401-11. PubMed ID: 22309983
[TBL] [Abstract][Full Text] [Related]
9. Analgesic Effect of Intrathecal Administration of Chemokine Receptor CCR2 Antagonist is Related to Change in Spinal NR2B, nNOS, and SIGIRR Expression in Rat with Bone Cancer Pain.
Ren F; Jiao H; Cai H
Cell Biochem Biophys; 2015 Jun; 72(2):611-6. PubMed ID: 25653100
[TBL] [Abstract][Full Text] [Related]
10. NR2B phosphorylation at tyrosine 1472 in spinal dorsal horn contributed to N-methyl-D-aspartate-induced pain hypersensitivity in mice.
Li S; Cao J; Yang X; Suo ZW; Shi L; Liu YN; Yang HB; Hu XD
J Neurosci Res; 2011 Nov; 89(11):1869-76. PubMed ID: 21800351
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA.
Zhang R; Liu Y; Zhang J; Zheng Y; Gu X; Ma Z
Pharmacol Biochem Behav; 2012 Jul; 102(1):139-45. PubMed ID: 22503970
[TBL] [Abstract][Full Text] [Related]
12. Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain.
D'Mello R; Marchand F; Pezet S; McMahon SB; Dickenson AH
Mol Ther; 2011 Oct; 19(10):1780-92. PubMed ID: 21427709
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the spinal NMDA receptor/PKCĪ³ signaling pathway in the development of bone cancer pain.
Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M
Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide synthase in the development of bone cancer pain and effect of L-NMMA.
Yang Y; Zhang J; Liu Y; Zheng Y; Bo J; Zhou X; Wang J; Ma Z
Mol Med Rep; 2016 Feb; 13(2):1220-6. PubMed ID: 26648027
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95.
Fan J; Vasuta OC; Zhang LY; Wang L; George A; Raymond LA
J Neurochem; 2010 Nov; 115(4):1045-56. PubMed ID: 20831617
[TBL] [Abstract][Full Text] [Related]
18. Activation of GRs-Akt-nNOs-NR2B signaling pathway by second dose GR agonist contributes to exacerbated hyperalgesia in a rat model of radicular pain.
Zhang J; Zhang W; Sun Y; Liu Y; Song L; Ma Z; Gu X
Mol Biol Rep; 2014 Jun; 41(6):4053-61. PubMed ID: 24562683
[TBL] [Abstract][Full Text] [Related]
19. N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression.
Huang LE; Guo SH; Thitiseranee L; Yang Y; Zhou YF; Yao YX
Sci Rep; 2018 May; 8(1):7848. PubMed ID: 29777135
[TBL] [Abstract][Full Text] [Related]
20. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain.
Wang W; Mei XP; Wei YY; Zhang MM; Zhang T; Wang W; Xu LX; Wu SX; Li YQ
Brain Behav Immun; 2011 Oct; 25(7):1355-66. PubMed ID: 21496481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
